According to our latest market study “Amniotic Products Market Forecast to 2028 – Impact of COVID-19 and Global Analysis by Type (Amniotic membranes [Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes] and amniotic suspensions), application (wound care, orthopaedics, ophthalmology and other applications), end users (hospitals and clinics, ambulatory surgical centers and other end users)

The amniotic products market is expected to grow from US$1,164.32 million in 2022 to US$1,889.07 million in 2028. It is estimated to grow at a CAGR of 8.4% from 2022 to 2028.

Traumatic wounds represent a significant clinical, social, and economic burden due to rising health care expenditures, an aging population, the identification of elusive infectious risks such as biofilms, and the global threat of diabetes and obesity. Traumatic wounds are those that have not undergone the normal healing process and have been open for more than a month. Compared to the overall burden of chronic wounds as a health problem, research funding for research into chronic wounds is disproportionately low. Wound healing with amniotic membrane grafts has some therapeutic potential. The early use of an amniotic membrane for ulcers, burns and skin injuries proved therapeutic. Therefore, an increasing number of traumatic wounds is fueling the market for amniotic products.

The sample PDF shows the content structure and the type of information included in the report, which presents a qualitative and quantitative analysis.
https://www.theinsightpartners.com/sample/TIPRE00028918/

Key players profiled in this study include

• MiMedx
• Blacksmith & Nephew
• Integra Life Sciences
• Strings
• organogenesis
• Katena Products, Inc.
• NuVision Biotherapies Ltd.
• Lucina BioSciences
• Next Life Sciences
• Sanuwave and Sanuwave Health, Inc.

Report coverage details

Market size value in US$ 1,164.32 million in 2022

Market size US$ value…